Neuropsychiatric Disease and Treatment (Nov 2024)

Towards a Non-pharmacological Intervention on Apathy in Korsakoff’s Syndrome: A Systematic Narrative Review Across Different Clinical Conditions

  • van Dorst MEG,
  • Rensen YCM,
  • Nijsten JMH,
  • Janssen GTL,
  • Kessels RPC

Journal volume & issue
Vol. Volume 20
pp. 2125 – 2144

Abstract

Read online

Maud EG van Dorst,1,2 Yvonne CM Rensen,2 Johanna MH Nijsten,3,4 Gwenny TL Janssen,2 Roy PC Kessels1,2,5,6 1Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands; 2Centre of Excellence for Korsakoff and Alcohol-Related Cognitive Disorders, Vincent van Gogh Institute for Psychiatry, Venray, the Netherlands; 3Knowledge Centre for Specialized Care, Archipel, Eindhoven, the Netherlands; 4Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands; 5Tactus Addiction Care, Deventer, the Netherlands; 6Klimmendaal Rehabilitation Center, Arnhem, the NetherlandsCorrespondence: Roy PC Kessels, Vincent van Gogh Institute for Psychiatry, Centre of Excellence for Korsakoff and Alcohol-Related Cognitive Disorders, D’n Herk 90, DN Venray, 5803, the Netherlands, Tel +31478-786160, Email [email protected]: Apathy is a quantitative reduction of goal-directed activity, which can be observed in relation to behavior, cognition, emotions and social interaction. It is an invalidating behavioral symptom that is frequently present across different psychiatric conditions and neurocognitive disorders including Korsakoff’s Syndrome (KS). In fact, apathy is one of the most severe behavioral symptoms of KS and has a major impact on the lives of patients and their relatives and other informal caregivers. However, guidelines for the treatment of apathy in KS are currently not available. This systematic narrative review provides a transdiagnostic overview of the effectiveness of different types of non-pharmacological interventions on apathy across different study populations that at symptom-level share characteristics with KS. This evidence may inform the development of an intervention targeting apathy in KS. The included study populations are dementia (due to Alzheimer’s disease, or vascular dementia), Parkinson’s disease, schizophrenia and traumatic brain injury. Through a stepped selection approach and with regard to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 22 systematic reviews and 32 empirical articles on the non-pharmacological treatment of apathy were identified. The results show a variety of effective non-pharmacological interventions on apathy. In conditions with severe cognitive impairments, successful interventions did not rely on intrinsic motivation, self-monitoring, or illness insight of the patients, but depend on external stimulation and behavioral activation. Since apathy is a multidimensional construct, identification of the extent and type of apathetic behavior before starting an intervention is highly recommended. Furthermore, it is important to adjust the treatment to the patients’ personal interests and needs and embedded in daily care.Trial registration: CRD42022298464 (PROSPERO).Keywords: non-pharmacological treatment, neuropsychiatric symptoms, alcohol use disorder, dementia, Parkinson’s disease, acquired brain injury

Keywords